CIK 0000883984 · Large accelerated filer
ICU MEDICAL INC/DE
Sign in to watch- Ticker
- ICUI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330022692
- Phone
- 949-366-2183
- Business address
- 951 CALLE AMANECER, SAN CLEMENTE, CA, 92763-6212
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,543,969
- in 3 filings, $3.5M under 10b5-1 plans
Net −$3,543,969. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-07 | Sanzone Virginia Ruth VP, General Counsel | Shares withheld for taxes | −625 | $141.97 | $89K | 4,930 |
| 2025-03-07 | Sanzone Virginia Ruth VP, General Counsel | Option exercise · Common Stock | −1,073 | 0 | ||
| 2025-03-07 | Sanzone Virginia Ruth VP, General Counsel | Grant or award · Common Stock | +7,044 | 16,612 | ||
| 2025-03-07 | Jain Vivek Chairman and CEO | Shares withheld for taxes | −1,775 | 102,818 | ||
| 2025-03-07 | Jain Vivek Chairman and CEO | Option exercise | +3,218 | 106,036 | ||
| 2025-03-07 | Jain Vivek Chairman and CEO | Option exercise · Common Stock | −3,218 | 0 | ||
| 2025-01-02 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +1,373 | $88.76 | $122K | 105,966 |
| 2025-01-02 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −1,373 | $155.48 | $213K | 104,593 |
| 2025-01-02 | Jain Vivek Chairman and CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,373 | 0 | ||
| 2024-12-06 | Woolson Daniel VP, GM-Infusion Capital | Sale | −2,241 | $156.25 | $350K | 10,866 |
| 2024-12-02 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +12,000 | $88.76 | $1.1M | 116,593 |
| 2024-12-02 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,672 | $162.29 | $596K | 112,921 |
| 2024-12-02 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −8,250 | $163.18 | $1.3M | 104,671 |
| 2024-12-02 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −78 | $163.96 | $13K | 104,593 |
| 2024-12-02 | Jain Vivek Chairman and CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −12,000 | 1,373 | ||
| 2024-11-27 | Voigtlander Christian B. Chief Operating Officer | Option exercise | +1,430 | $96.83 | $138K | 1,430 |
| 2024-11-27 | Voigtlander Christian B. Chief Operating Officer | Sale | −1,430 | $158.00 | $226K | 0 |
| 2024-11-27 | Voigtlander Christian B. Chief Operating Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −1,430 | 55,556 | ||
| 2024-11-27 | Greenberg David C. Director | Option exercise | +972 | $94.68 | $92K | 6,009 |
| 2024-11-27 | Greenberg David C. Director | Sale | −972 | $158.11 | $154K | 5,037 |
Page 12 of 44 · 868 trades